Skip to main content
Premium Trial:

Request an Annual Quote

PerkinElmer Says Acquisitions Could Help It Bolster Cell Reagent Play

GENEVA, Sept. 16 (GenomeWeb News) - PerkinElmer is "highly interested" in investing in its cell-based assay and reagent businesses, and will likely attempt to obtain core competencies in these areas through acquisition, partnerships, or both in the coming year, a PerkinElmer official said at the Society for Biomolecular Screening conference here this week.


Deb Brusini, business unit leader for drug discovery within PerkinElmer's Life and Analytical Sciences division, said in an interview with GenomeWeb News sister publication Cell-Based Assay News that the company will be looking to add reagents such as advanced photoproteins to better enable its newly launched LumiLux high-throughput live-cell ion-channel screening instrument.


The company will also aim to obtain optimized cell lines with the hope of enabling "mix-and-measure"-type assays on its CellLux and LumiLux instruments and, further in the future, acquire optimized reagents for conducting FRAP and FRET analysis on its UltraView confocal reader.


Brusini said that although PerkinElmer already has internal programs in place to address the development of these technologies, "it's very hard to get that internal capability on your own. So in the future what we'll be doing a lot of is acquiring competency in this area, as well as looking for technology to acquire in this area.


"The things that we'll be interested in will be anything that will allow these live-cell assays to be done more effectively," Brusini said.


Examples of possibly attainable companies with core competencies and key technologies in this area include Danish biotech BioImage and Italian biotech Axxam, though Brusini stressed that PerkinElmer is not necessarily interested in acquiring those particular companies. Brusini also said that Invitrogen would be an example of a company that would be attractive for a partnership in this area.


An extended version of this article appears in the current issue of Cell-Based Assay News.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.